Cantitate/Preț
Produs
Total produse
Vezi coșul
Bioactive Sphingolipids in Cancer Biology and Therapy de Yusuf A. Hannun

Bioactive Sphingolipids in Cancer Biology and Therapy

Editat de Yusuf A. Hannun, Chiara Luberto, Cungui Mao, Lina Marie Obeid
en Limba Engleză Hardback – 10 sep 2015
This volume presents information on both the basic and clinical aspects of sphingolipid-metabolizing enzymes in various cancers. The volume also includes discussions of the innovative techniques and approaches for quantitative analysis and imaging that could significantly impact the general understanding of this topic, and the potential benefit of targeting sphingolipid enzymes to develop novel cancer therapeutics. As well, the volume includes a critical examination of the specific pathways and pathobiologies associated with the altered regulation of sphingolipid metabolism as a contributor to the development and/or maintenance of pathological conditions such as cancer.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 100061 lei  38-44 zile
  Springer International Publishing – 21 oct 2016 100061 lei  38-44 zile
Hardback (1) 112682 lei  3-5 săpt.
  Springer International Publishing – 10 sep 2015 112682 lei  3-5 săpt.

Preț: 112682 lei

Preț vechi: 118612 lei
-5% Nou

Puncte Express: 1690
Preț estimativ în valută:
21565€ • 22323$ • 18227£

Carte disponibilă

Livrare economică 12-26 februarie

 Adaugă în coș

Wish list
Gift list
Am citit!
Adaugă în listă
Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9783319207490
ISBN-10: 3319207490
Pagini: 490
Ilustrații: XI, 490 p. 87 illus., 68 illus. in color.
Dimensiuni: 155 x 235 x 32 mm
Greutate: 1.23 kg
Ediția:1st ed. 2015
Editura: Springer International Publishing
Colecția Springer
Locul publicării:Cham, Switzerland

Public țintă

Research

Cuprins

.-1  Basics of Sphingolipid Metabolism and Signaling
.-2 Role of Sphingolipids in Hematological Malignancies: Lymphoproliferative disorders
.-3 Role of Sphingolipids in Hematological Malignancies: Myeloproliferative Disorders
.-4 Sphingolipids as Mediators of Breast Cancer Progression, Metastasis, Response, and Resistance to Chemotherapy
.-5 Role of Sphingolipids in Non-Melanoma Skin Cancer
.-6 Dysregulation of Sphingolipid Metabolism in Melanoma: Roles in Pigmentation, Cell Survival and Tumor Progression
.-7 Colon Cancer: the Role of Sphingolipid Metabolic Enzymes
.-8 Dietary Sphingolipids in Colon Cancer Prevention
.-9 Role of Sphingolipids in Liver Cancer
.-10 Pancreatic Cancer and Sphingolipids
.-11 Sphingolipids in the Pathogenesis of Head and Neck and Lung Cancers: Translational Aspects for Therapy and Biomarker Development
.-12 The Role and Function of Sphingolipids in Glioblastoma Multiforme
.-13 Systems Biology Approaches
for Studying Sphingolipid Signaling .-14 Qualitative and Quantitative Measurements of Sphingolipids by Mass Spectrometry
.-15 Detection and Distribution of Sphingolipids in Tissue by FTICR MALDI-Imaging Mass Spectrometry
.-16 Sphingoproteomics: Proteomic Strategies to Examine Sphingolipid Biology
.-17 Utilization of Caged Ceramide and Ceramide 1-Phosphate Analogs for Monitoring Cellular Events after Photoactivation
.-18 Chemotherapy and Sphingolipid Metabolism
.-19 Chemical Probes of Sphingolipid Metabolizing Enzymes
.-20 Use of Fenretinide to Increase Cytotoxic Dihydroceramides as a Novel Cancer Chemotherapeutic Approach

Notă biografică

Yusuf A. Hannun, MD, is Director, Stony Brook Cancer Center, Vice Dean, Cancer Medicine, and Professor, Biochemistry and Cell Biology, Stony Brook University. He is a renowned molecular biologist and physician-scientist investigating the molecular mechanisms of cancer, with an expertise in sphingolipids. Dr. Hannun is currently on the Editorial Board of several journals, including Biomedicine and Biotechnology, Frontiers in Membrane Physiology, and Biophysics, Chemistry and Physics of Lipids, and has received several honors, including the ASBMB Avanti Award in Lipids and ISI Highly Citied Researchers (in Biology and Biochemistry), and is Fellow, the American Association and Advancement of Science. He has published 448 scientific papers, which have received more than 34,100 citations.
 
Chiara Luberto, Ph.D., is Research Associate Professor of Physiology and Biophysics, Stony Brook University.
 
Cungui Mao, Ph.D., is Associate Professor of Medicine, Stony Brook University.
 
Lina Marie Obeid, M.D., is Professor of Medicine and Dean of Research, Stony Brook University.

Textul de pe ultima copertă

This volume presents information on both the basic and clinical aspects of sphingolipid-metabolizing enzymes in various cancers. The volume also includes discussions of the innovative techniques and approaches for quantitative analysis and imaging that could significantly impact the general understanding of this topic, and the potential benefit of targeting sphingolipid enzymes to develop novel cancer therapeutics. As well, the volume includes a critical examination of the specific pathways and pathobiologies associated with the altered regulation of sphingolipid metabolism as a contributor to the development and/or maintenance of pathological conditions such as cancer.

Caracteristici

Examines the roles and functions of sphingolipids in the development, progression and treatment of various cancers
Explores the use of innovative approaches for quantitative analysis and imaging which could have the potential benefit of helping to develop novel cancer therapeutics
Appeals to researchers in the fields of cancer and lipid metabolism/signaling